Global Cancer Targeted Therapy Market Status and Future Forecast 2015-2024

March 2019 | 177 pages | ID: G46522023F3EN
99Strategy

Abstracts

SUMMARY

The global Cancer Targeted Therapy market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Global Market by company, Type, Application & Geography
Part 3-4:
Asia-Pacific Market by company, Type, Application & Geography
Part 5-6:
Europe Market by company, Type, Application & Geography
Part 7-8:
North America Market by company, Type, Application & Geography
Part 9-10:
South America Market by company, Type, Application & Geography
Part 11-12:
Middle East & Africa Market by company, Type, Application & Geography
Part 13:
Company information, Sales, Cost, Margin etc.
Part 14:
Conclusion

Market Segment as follows:

By Region

• Global (Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru])

Key Companies

• Advaxis
• Bind Therapeutics
• Boehringer Ingelheim
• Bristol Mayer Squibb
• Celldex Therapeutics
• Dendreon Corporation
• Eli Lily
• GalaxoSmithKline
• Galena Biopharma
• Genetech
• ImmunoCellular Therapeutics
• ImmunoGen
• Inovio Pharmaceuticals
• Johnson & Johnson
• NeoStem Oncology
• NewLink Genetics
• Northwest Biotherapeutics
• Merck
• Novartis
• Peregrine Pharmaceuticals
• Pfizer
• Roche
• Sanofi
• Seattle Genetics
• Teva

Market by Type

• Tumor Antigens As Targets of Antibodies
• Development of Antibodies for Clinical Purposes
• Complement Dependent Cytotoxicity (CDC)
• Signal Transduction Changes

Market by Application

• Hospital
• Clinic
• Others

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
1.3 By Type
1.4 By Application
1.5 By Region

PART 2 GLOBAL MARKET STATUS AND FUTURE FORECAST

2.1 Global Market by Region
2.2 Global Market by Company
2.3 Global Market by Type
2.4 Global Market by Application
2.5 Global Market by Forecast

PART 3 ASIA-PACIFIC MARKET STATUS AND FUTURE FORECAST

3.1 Asia-Pacific Market by Company
3.2 Asia-Pacific Market by Type
3.3 Asia-Pacific Market by Application
3.4 Asia-Pacific Market by Forecast

PART 4 ASIA-PACIFIC MARKET BY GEOGRAPHY

4.1 China Market Status and Future Forecast
  4.1.1 China Market by Type
  4.1.2 China Market by Application
  4.1.3 China Market by Forecast
4.2 Southeast Asia Market Status and Future Forecast
  4.2.1 Southeast Asia Market by Type
  4.2.2 Southeast Asia Market by Application
  4.2.3 Southeast Asia Market by Forecast
4.3 India Market Status and Future Forecast
  4.3.1 India Market by Type
  4.3.2 India Market by Application
  4.3.3 India Market by Forecast
4.4 Japan Market Status and Future Forecast
  4.4.1 Japan Market by Type
  4.4.2 Japan Market by Application
  4.4.3 Japan Market by Forecast
4.5 Korea Market Status and Future Forecast
  4.5.1 Korea Market by Type
  4.5.2 Korea Market by Application
  4.5.3 Korea Market by Forecast
4.6 Oceania Market Status and Future Forecast
  4.6.1 Oceania Market by Type
  4.6.2 Oceania Market by Application
  4.6.3 Oceania Market by Forecast

PART 5 EUROPE MARKET STATUS AND FUTURE FORECAST

5.1 Europe Market by Region
5.2 Europe Market by Company
5.3 Europe Market by Type
5.4 Europe Market by Application
5.5 Europe Market by Forecast

PART 6 EUROPE MARKET BY GEOGRAPHY

6.1 Germany Market Status and Future Forecast
  6.1.1 Germany Market by Type
  6.1.2 Germany Market by Application
  6.1.3 Germany Market by Forecast
6.2 UK Market Status and Future Forecast
  6.2.1 UK Market by Type
  6.2.2 UK Market by Application
  6.2.3 UK Market by Forecast
6.3 France Market Status and Future Forecast
  6.3.1 France Market by Type
  6.3.2 France Market by Application
  6.3.3 France Market by Forecast
6.4 Italy Market Status and Future Forecast
  6.4.1 Italy Market by Type
  6.4.2 Italy Market by Application
  6.4.3 Italy Market by Forecast
6.5 Russia Market Status and Future Forecast
  6.5.1 Russia Market by Type
  6.5.2 Russia Market by Application
  6.5.3 Russia Market by Forecast
6.6 Spain Market Status and Future Forecast
  6.6.1 Spain Market by Type
  6.6.2 Spain Market by Application
  6.6.3 Spain Market by Forecast
6.7 Netherlands Market Status and Future Forecast
  6.7.1 Netherlands Market by Type
  6.7.2 Netherlands Market by Application
  6.7.3 Netherlands Market by Forecast
6.8 Turkey Market Status and Future Forecast
  6.8.1 Turkey Market by Type
  6.8.2 Turkey Market by Application
  6.8.3 Turkey Market by Forecast
6.9 Switzerland Market Status and Future Forecast
  6.9.1 Switzerland Market by Type
  6.9.2 Switzerland Market by Application
  6.9.3 Switzerland Market by Forecast

PART 7 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

7.1 North America Market by Region
7.2 North America Market by Company
7.3 North America Market by Type
7.4 North America Market by Application
7.5 North America Market by Forecast

PART 8 NORTH AMERICA MARKET BY GEOGRAPHY

8.1 United States Market Status and Future Forecast
  8.1.1 United States Market by Type
  8.1.2 United States Market by Application
  8.1.3 United States Market by Forecast
8.2 Canada Market Status and Future Forecast
  8.2.1 Canada Market by Type
  8.2.2 Canada Market by Application
  8.2.3 Canada Market by Forecast
8.3 Mexico Market Status and Future Forecast
  8.3.1 Mexico Market by Type
  8.3.2 Mexico Market by Application
  8.3.3 Mexico Market by Forecast

PART 9 SOUTH AMERICA MARKET STATUS AND FUTURE FORECAST

9.1 South America Market by Region
9.2 South America Market by Company
9.3 South America Market by Type
9.4 South America Market by Application
9.5 South America Market by Forecast

PART 10 SOUTH AMERICA MARKET BY GEOGRAPHY

10.1 Brazil Market Status and Future Forecast
  10.1.1 Brazil Market by Type
  10.1.2 Brazil Market by Application
  10.1.3 Brazil Market by Forecast
10.2 Argentina Market Status and Future Forecast
  10.2.1 Argentina Market by Type
  10.2.2 Argentina Market by Application
  10.2.3 Argentina Market by Forecast
10.3 Columbia Market Status and Future Forecast
  10.3.1 Columbia Market by Type
  10.3.2 Columbia Market by Application
  10.3.3 Columbia Market by Forecast
10.4 Chile Market Status and Future Forecast
  10.4.1 Chile Market by Type
  10.4.2 Chile Market by Application
  10.4.3 Chile Market by Forecast
10.5 Peru Market Status and Future Forecast
  10.5.1 Peru Market by Type
  10.5.2 Peru Market by Application
  10.5.3 Peru Market by Forecast

PART 11 MIDDLE EAST & AFRICA MARKET STATUS AND FUTURE FORECAST

11.1 Middle East & Africa Market by Region
11.2 Middle East & Africa Market by Company
11.3 Middle East & Africa Market by Type
11.4 Middle East & Africa Market by Application
11.5 Middle East & Africa Market by Forecast

PART 12 MIDDLE EAST & AFRICA MARKET BY GEOGRAPHY

12.1 GCC Market Status and Future Forecast
  12.1.1 GCC Market by Type
  12.1.2 GCC Market by Application
  12.1.3 GCC Market by Forecast
12.2 North Africa Market Status and Future Forecast
  12.2.1 North Africa Market by Type
  12.2.2 North Africa Market by Application
  12.2.3 North Africa Market by Forecast
12.3 South Africa Market Status and Future Forecast
  12.3.1 South Africa Market by Type
  12.3.2 South Africa Market by Application
  12.3.3 South Africa Market by Forecast

PART 13 KEY COMPANIES

13.1 Advaxis
  13.1.1 Company Profile
  13.1.2 Products & Services Overview
  13.1.3 Sales Data List
13.2 Bind Therapeutics
13.3 Boehringer Ingelheim
13.4 Bristol Mayer Squibb
13.5 Celldex Therapeutics
13.6 Dendreon Corporation
13.7 Eli Lily
13.8 GalaxoSmithKline
13.9 Galena Biopharma
13.10 Genetech
13.11 ImmunoCellular Therapeutics
13.12 ImmunoGen
13.13 Inovio Pharmaceuticals
13.14 Johnson & Johnson
13.15 NeoStem Oncology
13.16 NewLink Genetics
13.17 Northwest Biotherapeutics
13.18 Merck
13.19 Novartis
13.20 Peregrine Pharmaceuticals
13.21 Pfizer
13.22 Roche
13.23 Sanofi
13.24 Seattle Genetics
13.25 Teva

PART 14 CONCLUSION